175 related articles for article (PubMed ID: 25519886)
21. Clinicopathologic, immunophenotypic and ultrastructrual analyses of ATLL patients with cutaneous involvement.
Wang C; Yao Z; Liao J; Luo Y; Ma Y; Chen G; Zhu W
Chin Med J (Engl); 1999 May; 112(5):461-5. PubMed ID: 11593520
[TBL] [Abstract][Full Text] [Related]
22. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
23. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
[TBL] [Abstract][Full Text] [Related]
24. The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis.
Moles R; Nicot C
Viruses; 2015 Jul; 7(7):4047-74. PubMed ID: 26205403
[TBL] [Abstract][Full Text] [Related]
25. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
26. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
Nakahata S; Morishita K
J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
[TBL] [Abstract][Full Text] [Related]
27. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
[TBL] [Abstract][Full Text] [Related]
28. Repression of IRF-4 target genes in human T cell leukemia virus-1 infection.
Mamane Y; Grandvaux N; Hernandez E; Sharma S; Innocente SA; Lee JM; Azimi N; Lin R; Hiscott J
Oncogene; 2002 Oct; 21(44):6751-65. PubMed ID: 12360402
[TBL] [Abstract][Full Text] [Related]
29. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
Mortreux F; Gabet AS; Wattel E
Leukemia; 2003 Jan; 17(1):26-38. PubMed ID: 12529656
[TBL] [Abstract][Full Text] [Related]
30. Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype.
Zane L; Sibon D; Mortreux F; Wattel E
Front Biosci (Landmark Ed); 2009 Jan; 14(10):3935-41. PubMed ID: 19273324
[TBL] [Abstract][Full Text] [Related]
31. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma.
Nakahata S; Saito Y; Hamasaki M; Hidaka T; Arai Y; Taki T; Taniwaki M; Morishita K
Genes Chromosomes Cancer; 2009 Sep; 48(9):768-76. PubMed ID: 19484761
[TBL] [Abstract][Full Text] [Related]
32. Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB.
Jain P; Lavorgna A; Sehgal M; Gao L; Ginwala R; Sagar D; Harhaj EW; Khan ZK
Retrovirology; 2015 Feb; 12():23. PubMed ID: 25809782
[TBL] [Abstract][Full Text] [Related]
33. [HTLV-1: multistep leukemogenesis of adult T-cell leukemia].
Fujii M; Higuchi M; Endo K; Takahashi T; Ohhashi M; Tezuka T; Shinohara H; Hirata A; Mori N
Uirusu; 2002 Jun; 52(1):103-8. PubMed ID: 12227157
[No Abstract] [Full Text] [Related]
34. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma.
Nicot C
Am J Hematol; 2005 Mar; 78(3):232-9. PubMed ID: 15726602
[TBL] [Abstract][Full Text] [Related]
35. HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.
Zane L; Sibon D; Capraro V; Galia P; Karam M; Delfau-Larue MH; Gilson E; Gessain A; Gout O; Hermine O; Mortreux F; Wattel E
Int J Cancer; 2012 Aug; 131(4):821-33. PubMed ID: 21717459
[TBL] [Abstract][Full Text] [Related]
36. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.
Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M
J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297
[TBL] [Abstract][Full Text] [Related]
37. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Forlani G; Abdallah R; Accolla RS; Tosi G
J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
[TBL] [Abstract][Full Text] [Related]
38. Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.
Shigemura T; Shiohara M; Kato M; Furuta S; Kaneda K; Morishita K; Hasegawa H; Fujii M; Gorlach A; Koike K; Kamata T
J Virol; 2015 Sep; 89(17):9080-9. PubMed ID: 26109726
[TBL] [Abstract][Full Text] [Related]
39. How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?
Bangham CR; Ratner L
Curr Opin Virol; 2015 Oct; 14():93-100. PubMed ID: 26414684
[TBL] [Abstract][Full Text] [Related]
40. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.
Yoshida M
Annu Rev Immunol; 2001; 19():475-96. PubMed ID: 11244044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
